MoonLake Immunotherapeutics Faces Securities Fraud Allegations After Stock Crash

New York, Monday, 20 October 2025.
MoonLake Immunotherapeutics is under investigation for securities fraud following a 90% stock drop after disappointing trial results, with a class action lawsuit deadline on December 15, 2025.